Lu, H <br/><br/>
One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Dec 2001 
 - 1975-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2001.01122.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Amoxicillin--therapeutic use<br/>Anti-Bacterial Agents--therapeutic use<br/>Anti-Infective Agents, Local--therapeutic use<br/>Anti-Ulcer Agents--adverse effects<br/>Bismuth--adverse effects<br/>Diarrhea--chemically induced<br/>Dizziness--chemically induced<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Exanthema--chemically induced<br/>Female<br/>Furazolidone--therapeutic use<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Penicillins--therapeutic use<br/>Prospective Studies<br/>Pruritus--chemically induced<br/>Ranitidine--adverse effects<br/>Tetracycline--therapeutic use<br/>Treatment Outcome<br/>Vomiting--chemically induced